Evaluation of the Effectiveness of Group B Streptococcal Disease Prevention Guidelines
Group B Streptococcus (GBS) is the leading cause of bacterial infection in newborns in the United States. This project will assess a number of issues that affect successful management of GBS disease in the United States.
AGENCY SPONSOR: National Center for Infectious Diseases
FEDERAL CONTACT: Schuchat, MD, Anne
PIC ID: 6333
PERFORMER: American Association of Health Plans
EXPECTED DATE OF COMPLETION: 09/30/2000